Previous 10 |
NEW YORK, NY / ACCESSWIRE / October 22, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Flex Pharma, Inc. (NASDAQ: FLKS) a biotechnology company focused on develop...
InsiderInsights' Daily Round-Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
NEW YORK, NY / ACCESSWIRE / October 16, 2018 / U.S. markets failed to remain in the green on Monday as a technology sector selloff erased earlier gains. Tech giants Netflix and Apple both dropped more than 1.8 percent after analysts change their price targets on the stocks. The Dow Jones Ind...
NEW YORK, NY / ACCESSWIRE / October 3, 2018 / Wall Street closed mostly lower on Tuesday with the Dow Jones posting its fourth consecutive daily gain, however broader market dropped over trade related concerns. The Dow Jones Industrial Average gained 0.46 percent to close at 26,773.94, its 1...
News, Short Squeeze, Breakout and More Instantly...
FTSE Lujain Kuwait Shariah Index Company Name:
FLKS Stock Symbol:
NASDAQ Market:
FTSE Lujain Kuwait Shariah Index Website:
Flex Pharma, Inc. (Nasdaq: FLKS) announced that its Board of Directors today declared a special dividend on the Company’s common stock of one right per share of outstanding common stock. The rights will be paid on July 19, 2019 to shareholders of record as of close of business on July ...
Flex Pharma, Inc. (Nasdaq: FLKS) today announced that its stockholders approved all proposals relating to its planned merger with Salarius Pharmaceuticals, LLC at Flex Pharma’s special meeting of stockholders. Flex Pharma will file a Form 8-K to disclose detailed voting results for eac...
Flex Pharma, Inc. (Nasdaq: FLKS) today announced that on or about June 27, 2019 it will mail a supplement (the “Supplement”) to its proxy materials to provide stockholders with updated information regarding brokers’ discretionary authority to vote stockholders’ sha...